Low Availability of Orphan Medicines in Serbia

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.596
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Php162 - Licenced Orphan Medicines Expenditure in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Orphan Medicines: The High Cost of Hope

Prescriber
Pharmacology
2018English

Availability of Essential Medicines for Pediatric Oncology in Armenia

Asian Pacific Journal of Cancer Prevention
2019English

Psy147 - Availability and Reimbursement of Orphan Drugs in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php109 - Cost of Unlicenced and Orphan Medicines in Turkey, Kazakhstan and Poland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PRS17 Availability, Affordability and Price of Asthma Medicines in Tehran; Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Availability as a Dimension of Energy Security in the Republic of Serbia

Thermal Science
Renewable Energythe EnvironmentSustainability
2017English

Access to Essential Medicines in Ghana: A Survey of Availability of Children's Medicines in Medicine Outlets in the Ashanti Region

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2016English

Availability, Pricing and Affordability of Selected Medicines for Noncommunicable Diseases

Eastern Mediterranean Health Journal
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy